» Articles » PMID: 34209167

Exploring the Oral Microbiome in Rheumatic Diseases, State of Art and Future Prospective in Personalized Medicine with an AI Approach

Overview
Journal J Pers Med
Date 2021 Jul 2
PMID 34209167
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The oral microbiome is receiving growing interest from the scientific community, as the mouth is the gateway for numerous potential etiopathogenetic factors in different diseases. In addition, the progression of niches from the mouth to the gut, defined as "oral-gut microbiome axis", affects several pathologies, as rheumatic diseases. Notably, rheumatic disorders (RDs) are conditions causing chronic, often intermittent pain affecting the joints or connective tissue. In this review, we examine evidence which supports a role for the oral microbiome in the etiology and progression of various RDs, including rheumatoid arthritis (RA), Sjogren's syndrome (SS), and systemic lupus erythematosus (SLE). In addition, we address the most recent studies endorsing the oral microbiome as promising diagnostic biomarkers for RDs. Lastly, we introduce the concepts of artificial intelligence (AI), in particular, machine learning (ML) and their general application for understanding the link between oral microbiota and rheumatic diseases, speculating the application of a possible AI approach-based that can be applied to personalized medicine in the future.

Citing Articles

Periodontal bacteria influence systemic diseases through the gut microbiota.

Xi M, Ruan Q, Zhong S, Li J, Qi W, Xie C Front Cell Infect Microbiol. 2024; 14:1478362.

PMID: 39619660 PMC: 11604649. DOI: 10.3389/fcimb.2024.1478362.


Oral Microbiome: A Review of Its Impact on Oral and Systemic Health.

Rajasekaran J, Krishnamurthy H, Bosco J, Jayaraman V, Krishna K, Wang T Microorganisms. 2024; 12(9).

PMID: 39338471 PMC: 11434369. DOI: 10.3390/microorganisms12091797.


Personalized identification of autism-related bacteria in the gut microbiome using explainable artificial intelligence.

Novielli P, Romano D, Magarelli M, Diacono D, Monaco A, Amoroso N iScience. 2024; 27(9):110709.

PMID: 39286497 PMC: 11402656. DOI: 10.1016/j.isci.2024.110709.


Current Approaches to Prevent or Reverse Microbiome Dysbiosis in Chronic Inflammatory Rheumatic Diseases.

Nkeck J, Tchuisseu-Kwangoua A, Pelda A, Tamko W, Hamadjoda S, Essama D Mediterr J Rheumatol. 2024; 35(2):220-233.

PMID: 39211023 PMC: 11350408. DOI: 10.31138/mjr.240224.cap.


Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship.

Vegda H, Patel B, Girdhar G, Pathan M, Ahmad R, Haque M Cureus. 2024; 16(7):e63775.

PMID: 39100036 PMC: 11297857. DOI: 10.7759/cureus.63775.


References
1.
Lim Y, Totsika M, Morrison M, Punyadeera C . The saliva microbiome profiles are minimally affected by collection method or DNA extraction protocols. Sci Rep. 2017; 7(1):8523. PMC: 5561025. DOI: 10.1038/s41598-017-07885-3. View

2.
Phillips R . Rheumatoid arthritis: Microbiome reflects status of RA and response to therapy. Nat Rev Rheumatol. 2015; 11(9):502. DOI: 10.1038/nrrheum.2015.109. View

3.
Leung K, Leung W, McMillan A . Supra-gingival microbiota in Sjögren's syndrome. Clin Oral Investig. 2007; 11(4):415-23. DOI: 10.1007/s00784-007-0132-1. View

4.
Coit P, Mumcu G, Ture-Ozdemir F, Unal A, Alpar U, Bostanci N . Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease. Clin Immunol. 2016; 169:28-35. DOI: 10.1016/j.clim.2016.06.002. View

5.
Sakkas L, Chen P, Platsoucas C . T-cell antigen receptors in rheumatoid arthritis. Immunol Res. 1994; 13(2-3):117-38. DOI: 10.1007/BF02918273. View